FAIM
DMTK

Financial Advocates Investment Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Financial Advocates Investment Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,080
Closed -$10.6K – 843
2024
Q1 		$10.6K Sell
15,080
-60
-0.4% -$68 ﹤0.01% 770
2023
Q4 		$26.5K Sell
15,140
-140
-0.9% -$204 ﹤0.01% 723
2023
Q3 		$22K Sell
15,280
-100
-0.7% -$250 ﹤0.01% 694
2023
Q2 		$40K Sell
15,380
-885
-5% -$2.65K ﹤0.01% 686
2023
Q1 		$59.9K Sell
16,265
-640
-4% -$2.69K ﹤0.01% 724
2022
Q4 		$29.9K Sell
16,905
-355
-2% -$944 ﹤0.01% 738
2022
Q3 		$68K Buy
17,260
+1,025
+6% +$6.3K 0.01% 730
2022
Q2 		$90K Buy
16,235
+1,555
+11% +$12.7K 0.01% 660
2022
Q1 		$216K Buy
14,680
+1,135
+8% +$15.2K 0.01% 667
2021
Q4 		$214K Buy
13,545
+235
+2% +$5.64K 0.01% 716
2021
Q3 		$427K Buy
+13,310
New +$468K 0.03% 513

Other funds holding DMTK

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $430M AUM 23.45% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $613M AUM 14.25% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

Financial Advocates Investment Management's DMTK Position: Q2 2024 in Review

Financial Advocates Investment Management sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 15,080 shares — an estimated $10.6K sold.

Financial Advocates Investment Management first reported a position in DMTK in Q3 2021 and held it in 11 quarters. The position peaked at $427K in Q3 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Financial Advocates Investment Management reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Financial Advocates Investment Management sold 15,080 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $10.6K.
  • Financial Advocates Investment Management first reported a position in DermTech, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Financial Advocates Investment Management's DermTech, Inc. Common Stock position peaked at $427K in Q3 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Financial Advocates Investment Management's 13F filing for Q2 2024, filed 29 Jul 2024.